Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors / Brooks, Jw; Pryce, G; Bisogno, T; Jaggar, Si; Hankey, Dj; Brown, P; Bridges, D; Ledent, C; Bifulco, M.; Rice, As; DI MARZO, V; Baker, D.. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 0014-2999. - 439:(2002), pp. 83-92.

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors

BIFULCO M.;
2002

2002
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors / Brooks, Jw; Pryce, G; Bisogno, T; Jaggar, Si; Hankey, Dj; Brown, P; Bridges, D; Ledent, C; Bifulco, M.; Rice, As; DI MARZO, V; Baker, D.. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 0014-2999. - 439:(2002), pp. 83-92.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/830328
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 70
social impact